Evidence map›Paper›PMID 29736334›Full record

ArticlePeerJ2018

Felix Heiner, Björn Feistel, Michael Wink

Abstract read
In one paragraph

Article in PeerJ, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Characterization of theMolecules (Basel, Switzerland) · 2024
    Trial
  2. Trial
  3. Molecules (Basel, Switzerland) · 2026
    Article
  4. Polyphenol Profile and Biological Activity of the Extracts fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Beneficial Effects ofAntioxidants (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Kombucha Fermentation of Olympus Mountain Tea (Foods (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Plants (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. A Leaf Extract ofAntioxidants (Basel, Switzerland) · 2021
    Article
  14. Biology · 2021
    Article
  15. Polyphenols and Other Bioactive Compounds ofMolecules (Basel, Switzerland) · 2020
    Review
  16. Review
  17. Greek Sage Exhibits Neuroprotective Activity against Amyloid Beta-Induced Toxicity.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Felix HeinerInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Björn FeistelFinzelberg GmbH & Co. KG, Andernach, Germany.
Michael WinkInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBeyond its traditional uses in the Balkan area,

methodsFor this purpose, we have chosen the nematode

resultsEssentially, the contents of all measured constituents increased with the lipophilicity of the extraction solvents. Treatment of transgenic DISCUSSION:

Indexed as

AlzheimerAmyloid-βCaenorhabditis elegansGreek mountain teaLamiaceaeNeurodegenerative diseasesNeuroprotectionSideritis scardica

Identifiers

PMID29736334
PMCPMC5933321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.